FDA Drug recall D-0207-2025
FOUZEE SugarLin HERBAL FORMULA capsules, 180 capsules per bottle, Sold and Distributed by Shoppers-Plaza, Hawthorne, CA 90250
- FDA Drug
- Class I
- ongoing
- Published 2025-01-29
On 2025-01-29 the FDA classified a Class I recall of FOUZEE SugarLin HERBAL FORMULA capsules, 180 capsules per bottle, Sold and Distributed by Shoppers-Plaza, Hawthorne, CA 90250 by Shoppers Plaza, citing marketed without an Approved NDA/ANDA; FDA laboratory analysis confirmed product tainted with undeclared metformin and glyburide.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0207-2025 |
| Classification | Class I |
| Status | ongoing |
| Initiated | 2024-12-16 |
| Published | 2025-01-29 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Shoppers Plaza |
| Distribution | US |
Product
FOUZEE SugarLin HERBAL FORMULA capsules, 180 capsules per bottle, Sold and Distributed by Shoppers-Plaza, Hawthorne, CA 90250. Product of India. UPC 8 26656 69047 7
Reason
Marketed without an Approved NDA/ANDA; FDA laboratory analysis confirmed product tainted with undeclared metformin and glyburide
Identifiers
| upc | 826656690477 |
|---|---|
| code_info | Batch # 001, exp. date 09/10/2026 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0207-2025%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.